Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Neuronetics, Inc. (STIM)

2.4300 -0.2750 (-10.17%)
At close: 4:00:01 PM EST
2.4800 +0.0500 (+2.06%)
After hours: 4:32:49 PM EST
STIM Q3 2026 earnings call
Replay the call for the latest insights.

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Daniel L. Reuvers
CEO, President & Director -- -- 1963
Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.
Executive VP, CFO, Corporate Secretary, Principal Financial and Accounting Officer & Treasurer -- -- 1975
Mr. Robert Greene
Senior Vice President of Sales -- -- --
Mr. Cory S. Anderson
Executive Vice President & General Manager of Greenbrook -- -- 1977

Neuronetics, Inc.

3222 Phoenixville Pike
Malvern, PA 19355
United States
877 600 7555 https://neurostar.com/neuronetics
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
658

Description

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Corporate Governance

Neuronetics, Inc.’s ISS Governance QualityScore as of November 1, 2026 is 7. The pillar scores are Audit: 6; Board: 4; Shareholder Rights: 7; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 4, 2026 at 1:30 PM UTC

Neuronetics, Inc. Earnings Date

Recent Events

November 4, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 17, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 11, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 20, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 23, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 29, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 22, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 5, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 9, 2026 at 12:00 AM UTC

DEF 14A: Proxy Statements

April 8, 2026 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: